These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Assessing endometrial hyperplasia and carcinoma treated with progestin therapy. Mentrikoski MJ, Shah AA, Hanley KZ, Atkins KA. Am J Clin Pathol; 2012 Oct; 138(4):524-34. PubMed ID: 23010707 [Abstract] [Full Text] [Related]
6. Apoptosis may be an early event of progestin therapy for endometrial hyperplasia. Amezcua CA, Lu JJ, Felix JC, Stanczyk FZ, Zheng W. Gynecol Oncol; 2000 Nov; 79(2):169-76. PubMed ID: 11063639 [Abstract] [Full Text] [Related]
10. Effects of hormone therapy on the endometrium. Deligdisch L. Mod Pathol; 1993 Jan; 6(1):94-106. PubMed ID: 8426860 [Abstract] [Full Text] [Related]
11. Endometrial squamous metaplasia. An unusual response to progestin therapy of hyperplasia. Miranda MC, Mazur MT. Arch Pathol Lab Med; 1995 May; 119(5):458-60. PubMed ID: 7748076 [Abstract] [Full Text] [Related]
12. Hyperplasia and carcinoma in secretory endometrium: a diagnostic challenge. Truskinovsky AM, Lifschitz-Mercer B, Czernobilsky B. Int J Gynecol Pathol; 2014 Mar; 33(2):107-13. PubMed ID: 24487463 [Abstract] [Full Text] [Related]
13. [Effects of pathological assessment of endometrial tissue in fertility-sparing treatment with progestin for endometrial carcinoma of stage I a and complex atypical hyperplasia]. Gong Q, Chen X, Xie X. Zhonghua Fu Chan Ke Za Zhi; 2014 Sep; 49(9):664-9. PubMed ID: 25487452 [Abstract] [Full Text] [Related]
14. Mucinous endometrial epithelial proliferations: a morphologic spectrum of changes with diverse clinical significance. Nucci MR, Prasad CJ, Crum CP, Mutter GL. Mod Pathol; 1999 Dec; 12(12):1137-42. PubMed ID: 10619266 [Abstract] [Full Text] [Related]
15. [Clinicopathological analysis in cases with glandular and atypical glandular hyperplasia treated with gestagens]. Ivanov S. Akush Ginekol (Sofiia); 2005 Dec; 44(4):18-20. PubMed ID: 16028373 [Abstract] [Full Text] [Related]
16. Down-regulation of bcl-2 is a potential marker of the efficacy of progestin therapy in the treatment of endometrial hyperplasia. Amezcua CA, Zheng W, Muderspach LI, Felix JC. Gynecol Oncol; 1999 Apr; 73(1):126-36. PubMed ID: 10094893 [Abstract] [Full Text] [Related]
17. [Modern tendencies in treatment of atypical glandular hyperplasia--our and foreign experience]. Ivanov S, Kovachev E, Tsonev A, Abbud A. Akush Ginekol (Sofiia); 2010 Apr; 49(2):47-9. PubMed ID: 20734678 [Abstract] [Full Text] [Related]
19. Clinical and pathological responses of progestin therapy for non-atypical endometrial hyperplasia: a prospective study. Rattanachaiyanont M, Angsuwathana S, Techatrisak K, Tanmahasamut P, Indhavivadhana S, Leerasiri P. J Obstet Gynaecol Res; 2005 Apr; 31(2):98-106. PubMed ID: 15771634 [Abstract] [Full Text] [Related]
20. Microcarcinoma of the endometrium: a mapping study with special reference to cytologic atypia in the endometrium. Hachisuga T, Sugimori H, Kaku T, Tsuneyoshi M. Jpn J Clin Oncol; 1992 Dec; 22(6):400-5. PubMed ID: 1291756 [Abstract] [Full Text] [Related] Page: [Next] [New Search]